Tag #Biologics

Showing 1 to 3 of 3 results

us.cnn.com
🌐 85% Global Worthiness
News related image

FDA Appoints Covid-19 Vaccine Critic to Lead Biologics Division

The FDA appointed Dr. Vinay Prasad, a vocal critic of its Covid-19 policies, to head its Center for Biologics Evaluation and Research, replacing Dr. Peter Marks who resigned after criticizing HHS Secretary Robert F. Kennedy Jr. This appointment caused a 5% drop in biotech stocks and prompted concern...

Progress

48% Bias Score

Good Health and Well-being
forbes.com
🌐 75% Global Worthiness
News related image

Pfizer Stock Up 5% on Positive 2025 Outlook

Pfizer's stock rose 5% on December 17, 2024, after projecting $61-$64 billion in 2025 revenue and $2.80-$3.00 adjusted earnings per share, driven by acquisitions and cost-cutting to offset declining Covid-19 vaccine sales.

Progress

36% Bias Score

Good Health and Well-being
elmundo.es
🌐 90% Global Worthiness
News related image

Eleven Blockbuster Drugs to Transform Medicine by 2030

Clarivate's 2025 Drugs to Watch report identifies eleven innovative medicines projected to become blockbusters by 2030, significantly impacting various therapeutic areas, with diabetes/obesity and atopic dermatitis treatments anticipated to lead in revenue generation.

Progress

36% Bias Score

Good Health and Well-being

Showing 1 to 3 of 3 results